REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
C144_LS | Dr. Michel Nussenzweig, The Rockefeller University | N/A |
C135_LS | Dr. Michel Nussenzweig, The Rockefeller University | N/A |
3BNC117_LS | Dr. Michel Nussenzweig, The Rockefeller University | N/A |
10-1074_LS | Dr. Michel Nussenzweig, The Rockefeller University | N/A |
Bacterial and virus strains | ||
SARS-CoV-2 mouse-adapted 10 (MA10) | Dr. Ralph Baric, UNC Chapel Hill | N/A |
SARS-CoV-2 MA10 B.1.351 spike | This paper | N/A |
Chemicals, peptides, and recombinant proteins | ||
Remdesivir | Gilead Sciences | GS-5734 (RDV) |
Vehicle [12% sulfobutylether-β-cyclodextrin in water (with HCl/NaOH) at pH 5] | Gilead Sciences | N/A |
Critical commercial assays | ||
mMESSAGE mMACHINE T7 Transcription Kit | ThermoFisher Scientific | AM1344 |
Experimental models: Cell lines | ||
Vero C1008 (E6) | ATCC | CRL-1586 |
Experimental models: Organisms/strains | ||
C57BL/6 Ces1c/ mice | Jackson Labs | Stock # 014096 |
C57BL/6J | Jackson Labs | Stock # 000664 |
BALB/c | Envigo | # 047 |
Oligonucleotides | ||
E gene forward primer: 5′ CGATCT CTTGTAGATCTGTTCTCE 3′ |
Integrated DNA Technologies | N/A |
E gene reverse primer: 5′ ATATT GCAGCAGT ACGCACACA 3′ |
Integrated DNA Technologies | N/A |
N gene forward primer: 5′ CGATC TCTTGTAGATCTGTTCTC 3′ |
Integrated DNA Technologies | N/A |
N gene reverse primer: 5′ GGTGAA CCAAGACGCAGTAT 3′ | Integrated DNA Technologies | N/A |
Software and algorithms | ||
Prism 9 | GraphPad | https://www.graphpad.com/scientific-software/prism/ |